TG Therapeutics Inc logo

TG Therapeutics Inc

NEW
STU:NKB2 (USA)   Ordinary Shares
€ 48.2 +1.7 (+3.66%) Sep 1
20.49
P/B:
14.22
Market Cap:
€ 7.39B ($ 8.56B)
Enterprise V:
€ 7.56B ($ 8.76B)
Volume:
200.00
Avg Vol (2M):
208.00
Trade In:

TG Therapeutics Inc Valuation Measures